Connect Biopharma Holdings LCNTB

13F holders, Q2 2026 (June 30)
55holders +15
24new positions
9sold out
2famous investors
$2.38avg. 13F price*

At the end of Q2 2026, 55 institutions reported holding Connect Biopharma Holdings L (CNTB) in their 13F filings, up 15 from Q1 2026. 24 opened new positions and 9 sold out. The largest holders were Ikarian Capital, LLC ($10.8M), 683 Capital Management, LLC ($3.1M) and Boothbay Fund Management, LLC ($2.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Connect Biopharma Holdings L
CUSIP
G23549101
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q3 2025: 15Q3 2025Q4 2025: 28Q4 2025Q1 2026: 40Q1 2026Q2 2026: 55Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions24$4.6M
Exits9$1.3M

All 13F filers, Q1 2026 → Q2 2026: 3,442,601 shares bought and 2,314,655 shares sold, net +1,127,946 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 55 holders

Ikarian Capital, LLC 1.77% Reduce -15.8% 4,538,534 $10.8M
683 Capital Management, LLC 0.29% Add +42.8% 1,285,000 $3.1M
Boothbay Fund Management, LLC 0.05% Reduce -21.1% 973,732 $2.3M
BlackRock, Inc. 0.00% New 871,653 $2.1M
Perceptive Advisors LLC 0.03% No change 792,696 $1.9M
ADAR1 Capital Management, LLC 0.08% Reduce -5.7% 700,000 $1.7M
BML Capital Management, LLC 0.78% Add +40.2% 573,287 $1.4M
Silverarc Capital Management, LLC 0.14% New 545,000 $1.3M
Richmond Brothers, Inc. 0.66% Add +12.4% 535,612 $1.3M
Knott David M Jr 0.56% Add +14.7% 444,862 $1.1M
Stonepine Capital Management, LLC 0.66% Add +17.5% 364,254 $867K
Marshall Wace, LLP 0.00% Add +408.4% 335,642 $799K
Geode Capital Management, LLC 0.00% Add +701.3% 257,454 $613K
Two Sigma Investments, LP 0.00% Add +320.1% 199,381 $475K
Diadema Partners LP 0.18% Reduce -1.9% 196,985 $469K
Burkehill Global Management, LP 0.01% No change 150,000 $357K
Vanguard Portfolio Management LLC 0.00% New 102,755 $245K
Susquehanna International Group, LLP 0.00% Reduce -63.4% 102,148 $243K
Renaissance Technologies 0.00% Reduce -27.7% 87,300 $208K
Northern Trust Corp. 0.00% New 82,862 $197K
Simplex Trading, LLC 0.01% New 81,948 $195K
State Street Corp. 0.00% New 66,700 $159K
UBS Group AG 0.00% Add +201266.7% 66,451 $158K
Persistent Asset Partners Ltd 0.04% Reduce -1.7% 49,873 $119K
Koa Wealth Management, LLC 0.08% No change 49,600 $118K
New York State Common Retirement Fund 0.00% New 48,400 $115K
Millennium Management 0.00% Reduce -90.8% 43,708 $104K
Bank of America Corp. 0.00% Add +161.1% 40,920 $97K
Royal Bank of Canada 0.00% Add +1.3% 40,940 $97K
Charles Schwab Investment Management Inc. 0.00% New 36,760 $87K
XTX Topco Ltd 0.00% Reduce -30.3% 28,659 $68K
Bank of New York Mellon Corp 0.00% New 23,953 $57K
Nuveen, LLC 0.00% New 19,773 $47K
Y-Intercept (Hong Kong) Ltd 0.00% New 15,069 $36K
Wells Fargo & Company 0.00% New 13,240 $32K
SmartHarvest Portfolios, LLC 0.01% No change 12,897 $31K
T. Rowe Price Associates Inc. 0.00% New 12,469 $30K
JPMorgan Chase & Co. 0.00% Add +9584.3% 11,718 $28K
Vanguard Fiduciary Trust Co. 0.00% New 11,314 $27K
Monograph Wealth Advisors, LLC 0.00% No change 11,130 $26K
Rhumbline Advisers 0.00% Add +1307.6% 10,979 $26K
Morgan Stanley 0.00% Add +140.6% 8,639 $21K
Citigroup Inc. 0.00% Add +698500.0% 6,986 $17K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% New 6,904 $16K
FNY Investment Advisers, LLC 0.00% No change 5,000 $11K
Barclays PLC 0.00% New 2,879 $7K
Legal & General Group Plc 0.00% New 2,415 $6K
BNP Paribas Financial Markets 0.00% New 2,290 $5K
Russell Investments Group, Ltd. 0.00% New 1,195 $3K
Huntington National Bank 0.00% New 996 $2K
Tower Research Capital LLC (TRC) 0.00% New 882 $2K
FMR LLC 0.00% New 314 $747
Sterling Capital Management LLC 0.00% New 150 $357
Caitong International Asset Management Co., Ltd 0.00% New 66 $157
SBI Securities Co., Ltd. 0.00% No change 6 $14

"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Holdings L the manager owns.